Private company
BLONDER TONGUE LABORATORIES INC
Last updated Oct 18, 2026.
Overview
Financials
From the company’s reports to the SEC. Every number links to the filing it came from.
Key numbers, fiscal 2022
30.2%Gross margin3
-11.8%Operating margin3
-16.1%Net margin3
15.0%Revenue growth, 20223
-271.9%Return on equity3
Where the money goes
Where each dollar of revenue went, fiscal 2022
- Cost of revenue70¢$12.7M
- Research and development10¢$1.8M
- Other costs16¢$2.9M
- Interest4¢$789.0K
Out of $18.1M in revenue.3 The company lost money this year.
Financial statements
No quarterly figures reported.
| Fiscal year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|---|---|
| Revenue | $22.5M4 | $23.3M5 | $21.7M6 | $19.8M7 | $16.4M8 | $15.8M3 | $18.1M3 |
| Cost of revenue | $14.1M4 | $14.3M5 | $13.3M6 | $16.4M7 | $13.4M8 | $9.9M3 | $12.7M3 |
| Gross profit | $8.4M4 | $8.9M5 | $8.4M6 | $3.4M7 | $3.0M8 | $5.9M3 | $5.5M3 |
| Research and development | $2.7M4 | $2.5M5 | $2.6M6 | $3.1M7 | $2.5M8 | $2.6M3 | $1.8M3 |
| Operating income | -$671.0K4 | $463.0K5 | -$854.0K6 | -$466.0K7 | -$7.1M8 | -$3.0M3 | -$2.1M3 |
| Interest | $412.0K4 | $723.0K5 | $562.0K6 | $261.0K7 | $345.0K8 | $514.0K3 | $789.0K3 |
| Income tax | $29.0K4 | -$18.0K5 | -$77.0K6 | $15.0K7 | $15.0K8 | $15.0K3 | |
| Net income | -$1.2M4 | -$384.0K5 | -$1.3M6 | -$742.0K7 | -$7.5M8 | $84.0K3 | -$2.9M3 |
| Earnings per share | -$0.768 | $0.013 | -$0.223 | ||||
| Earnings per share (diluted) | -$0.768 | $0.023 | -$0.223 |
No quarterly figures reported.
| Fiscal year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|---|---|
| Cash | $468.0K5 | $168.0K6 | $559.0K6 | $572.0K7 | $69.0K8 | $274.0K3 | $79.0K3 |
| Current assets | $8.1M4 | $8.9M5 | $10.4M6 | $12.2M7 | $6.1M8 | $7.7M3 | $8.0M3 |
| Total assets | $15.0M4 | $15.2M5 | $15.6M6 | $18.3M7 | $11.1M8 | $11.9M3 | $15.0M3 |
| Current liabilities | $4.6M4 | $3.9M5 | $8.3M6 | $8.4M7 | $5.5M8 | $6.1M3 | $8.2M3 |
| Long-term debt | $3.3M4 | $3.1M5 | $32.0K6 | $47.0K7 | $1.8M7 | ||
| Total liabilities | $8.5M4 | $7.8M5 | $8.4M6 | $11.0M7 | $9.9M8 | $8.6M3 | $13.9M3 |
| Shareholders’ equity | $6.5M5 | $7.4M6 | $7.2M7 | $7.4M8 | $1.2M3 | $3.3M3 | $1.1M3 |
| Shares outstanding | 8.1M shares4 | 8.2M shares5 | 9.3K shares6 | 9.8M shares7 | 11.6M shares8 | 13.0K shares3 | 13.3K shares3 |
Cash flow is reported year to date, not quarter by quarter, so there are no separate quarterly figures.
Compare BLONDER TONGUE LABORATORIES INC with another company
Recent filings
- Apr 28, 202310-K/A AMENDMENT NO. 1 TO FORM 10-K
- Apr 17, 202310-K ANNUAL REPORT
- Mar 1, 20238-K CURRENT REPORT
- Feb 13, 20238-K CURRENT REPORT
- Jan 23, 20238-K CURRENT REPORT
- Jan 6, 20238-K CURRENT REPORT
- Jan 3, 20234
- Jan 3, 20234
- Jan 3, 20234
- Dec 19, 20224
- Dec 19, 20224
- Dec 19, 20224
- Dec 5, 20224
- Dec 5, 20224
- Dec 5, 20224
Every filing from the last three years, summarized. The full record is on SEC EDGAR.1
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8